Medexus Pharmaceuticals (TSE:MDP) Trading Up 2.1% – What’s Next?

Medexus Pharmaceuticals Inc. (TSE:MDP)’s stock price traded up 2.1% during mid-day trading on Monday . The company traded as high as C$2.93 and last traded at C$2.93. 68,477 shares were traded during trading, an increase of 72% from the average session volume of 39,835 shares. The stock had previously closed at C$2.87.

Medexus Pharmaceuticals Stock Up 2.1%

The stock’s 50 day moving average price is C$2.78 and its two-hundred day moving average price is C$2.82. The firm has a market capitalization of C$94.99 million, a price-to-earnings ratio of 293.00 and a beta of 0.60.

Medexus Pharmaceuticals Company Profile

Medexus Pharmaceuticals Inc, formerly Pediapharm Inc is a leading specialty pharmaceutical company with a strong North American commercial platform. It is focused on the therapeutic areas of auto-immune disease and pediatrics. The leading products are Rasuvo and Metoject, a unique formulation of methotrexate to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an innovative allergy medication with a unique mode of action.